The Claim

Clonal hematopoiesis of indeterminate potential (CHIP) may be associated with systemic inflammation and altered red blood cell turnover, which could contribute to discordant HbA1c values in individuals who do not have anemia or hemoglobinopathy.

Source: Normal glycosylated hemoglobin masking glucose dysregulation in a patient with pancreatic and hematologic disease

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
24score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Sometimes, changes in blood cells that happen as people age might mess with blood sugar readings, even if their blood is otherwise healthy.

See the scientific wording

Clonal hematopoiesis of indeterminate potential (CHIP) may be associated with systemic inflammation and altered red blood cell turnover, contributing to discordant HbA1c values in the absence of anemia or hemoglobinopathy.

What the research says

1 study

  1. Study: Normal glycosylated hemoglobin masking glucose dysregulation in a patient with pancreatic and hematologic disease

    The study looks at a woman with a blood condition called CHIP and finds her blood sugar test (HbA1c) was normal even though her actual sugar levels were high. Doctors think CHIP may have changed how her red blood cells worked, making the test misleading.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.